Serum Myeloperoxidase, C-reactive Protein and α1-acid Glycoprotein: Insights about Cardiovascular Risk in End-stage

Cristiane Rickli1, Danielle Cristyane Kalva Borato1, Anderson José de Melo E Silva1

  • 1State University of Ponta Grossa - UEPG, Ponta Grossa-PR, Brazil.

Insights

Myeloperoxidase (MPO) levels were evaluated in patients with end-stage renal disease (ESRD). MPO was significantly lower in ESRD patients with cardiovascular disease (CVD), suggesting a potential role as a CVD risk marker.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in end-stage renal disease (ESRD) patients.
  • Elevated serum myeloperoxidase (MPO) concentrations are linked to increased CVD risk.
  • This study investigates MPO and other biomarkers in ESRD patients with and without CVD undergoing hemodialysis.

Purpose of the Study:

  • To evaluate serum MPO levels in individuals with ESRD.
  • To compare MPO levels in ESRD patients with and without co-existing CVD.
  • To assess other laboratory parameters, including hs-CRP and α1-acid glycoprotein, in these groups.

Main Methods:

  • A cohort of 80 volunteers was divided into three groups: control (CON, n=20), ESRD (n=45), and ESRD with CVD (ESRD/CVD, n=15).
  • Serum MPO, high-sensitivity C-reactive protein (hs-CRP), and α1-acid glycoprotein were measured.
  • Statistical analysis was performed using SPSS 20.0.

Main Results:

  • Serum MPO levels were significantly lower in the ESRD/CVD group (21 ng/mL) compared to both the control (84 ng/mL) and ESRD (77 ng/mL) groups (p<0.001).
  • hs-CRP and α1-acid glycoprotein levels differed significantly between the ESRD/CVD and control groups (p<0.0001), but not between ESRD and ESRD/CVD groups.
  • These findings indicate a distinct MPO profile in ESRD patients with CVD.

Conclusions:

  • The study suggests a potential role for MPO as a cardiovascular risk marker in hemodialysis patients with ESRD.
  • Further research is recommended to elucidate the precise function of MPO in this population.
  • Understanding MPO's role could lead to improved CVD risk stratification and management in ESRD patients.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
197
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
436
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
395
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
206
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
581